Jaime Moore is an assistant professor of pediatric nutrition at Childrens Hospital Colorado in Aurora and medical director of its Lifestyle Medicine Clinic, which treats pediatric obesity
This means early use of GLP-1 and SGLT2 inhibitors, especially in patients with established cardiovascular disease
This guide tells you exactly whats changed with compounded tirzepatide, what to stop, and what to do next to stay compliant
Routine Use Depends on the System Around the Therapy At an overall level, around two-thirds of clinicians said they routinely consider GLP-1 therapy for obesity independent of diabetes, while another quarter consider it occasionally
Ozempic is administered through a pre-filled, single-use, disposable pen once a week
People with high blood pressure, heart disease, arrhythmias, or anxiety disorders should not use yohimbine unless specifically cleared by a physician